181 Neb. Admin. Code, ch. 8, § 010

Current through September 17, 2024

Section 181-8-010 - [Effective until 3/29/2024] USE OF CROSS-SEX HORMONES

Prior to prescribing, dispensing, or administering cross-sex hormones for the treatment of gender nonconformity or gender dysphoria, prescribing practitioners must meet the following:

(A) Obtain three hours of Category 1 Continuing Competency Education for prescribing drugs for the purpose of treating gender nonconformity or gender dysphoria within the most recent biennial renewal period;

(B) Determine or document:

(i) Puberty blocking treatment, if occurring, has been successful at reducing patient distress and discomfort;

(ii) That gender nonconformity or gender dysphoria is driving the patient's distress and not other mental or physical health conditions, that there is no reasonable expectation of natural resolution of gender nonconformity, and that there has been a long-lasting and intense pattern of gender nonconformity or gender dysphoria which began or worsened at the start of puberty;

(iii) There is an expectation of increased distress if puberty blocking treatment is terminated or cross-sex hormone treatment is not initiated;

(iv) Cross-sex hormones would be effective and are not likely to negatively impact, or exacerbate other mental or physical health conditions;

(v) The patient has received at least 40 contact hours of therapeutic treatment as required by this chapter;

(vi) The patient has at least six consecutive months of living primarily as the preferred gender and has continued living primarily as the preferred gender;

(vii) For individuals not suffering from gender dysphoria or for whom a clinical diagnosis of gender dysphoria is not available, documentation that without cross-sex hormone treatment the patient will experience harm; and

(viii) The appropriate supports are in place for the patient including appropriate social, and familial support prior to initiating cross-sex hormone treatment;

(C) Discuss the following with the patient and parent or legal guardian or the patient, if the patient is an emancipated minor:

(i) The recommended dosage and route of treatment for the cross-sex hormones: and

(ii) The minimum waiting period of seven calendar days as required by this chapter;

(D) Obtain signed informed consent and patient assent as required by this chapter: and

(E) Document all the foregoing in the patient's medical record.

181 Neb. Admin. Code, ch. 8, § 010

Adopted effective 10/1/2023

Amended effective 1/2/2024, exp. 3/29/2024 (Emergency)